{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-027972","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2024-03-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.377919+00:00","generated_at":"2026-06-04T05:11:43.296457+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"China Pharma regains NYSE American compliance after reverse stock split","bullets":["Received NYSE American notice on March 27, 2024 confirming compliance with continued listing standards.","Resolved low selling price deficiency (Section 1003(f)(v)) via 1-for-5 reverse stock split on March 6, 2024.","\".BC\" indicator to be removed; company removed from noncompliant issuers list.","NYSE American cautioned that no cure period exists if stock again trades at abnormally low levels."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-027972","json":"https://secwatch.observer/filing/0001213900-24-027972.json","markdown":"https://secwatch.observer/filing/0001213900-24-027972.md","text":"https://secwatch.observer/filing/0001213900-24-027972.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390024027972/0001213900-24-027972-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390024027972/ea0202916-8k_chinapharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T05:11:43.296457+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}